Home › Onxeo: Belinostat Phase I/II Results in Soft Tissue Sarcoma to Be...
 

Keywords :   


Onxeo: Belinostat Phase I/II Results in Soft Tissue Sarcoma to Be...

2015-04-10 00:14:21| Logistics - Topix.net

PARIS & COPENHAGEN, Denmark-- -- Regulatory News: Onxeo S.A. , an innovative company specializing in the development of orphan oncology drugs, today announced that the phase I/II clinical trial of belinostat in combination with doxorubicin in patients with soft tissue sarcoma was accepted for presentation in the Poster Discussion Session at the 2015 Annual Meeting of the American Society of Clinical Oncology , taking place in Chicago, USA from May 29 to June 2, 2015. The PXD101-CLN-14 study was an open -label, multicenter, dose-escalation phase I/II to evaluate the safety and efficacy of the combination of belinostat with doxorubicin in patients with advanced solid tumors and STS .

Tags: to results iii soft

Category:Transportation and Logistics

Latest from this category

All news
15.11Tropical Storm Sara Forecast Discussion Number 9
15.11Tropical Storm Sara Wind Speed Probabilities Number 9
15.11Summary for Tropical Storm Sara (AT4/AL192024)
15.11Tropical Storm Sara Public Advisory Number 9
15.11Tropical Storm Sara Forecast Advisory Number 9
15.11Eastern North Pacific Tropical Weather Outlook
15.11Atlantic Tropical Weather Outlook
15.11Tropical Storm Sara Graphics
Transportation and Logistics »
15.11TOMIX 98693 183B
15.11 6014
15.11WBC L
15.11SHY
15.11 brightMEMORY A1aime
15.11
15.11JOCHUM JO1 LAPONE
15.11
More »